Colon cancer cases have doubled in people under 55 over the past two decades, a rise that has alarmed doctors and researchers worldwide. While the exact cause remains unclear, new evidence points to colibactin, a DNA-damaging toxin produced by certain strains of E. coli and other gut bacteria, as a possible contributor.
Study Links Colibactin to Early-Onset Cancer
A team from the University of California, San Diego analyzed tissue samples from nearly 1,000 colorectal cancer patients across four continents. They discovered that most tumors carried mutations consistent with past exposure to colibactin. Strikingly, patients under 40 with early-onset colon cancer were three to five times more likely to have these mutations than older patients.
Lead author Ludmil Alexandrov described colibactin as “a bacterial weapon system, originally meant to defend against other microbes, but one that can harm human gut cells and seed cancer-causing mutations.”
Childhood Exposure May Play a Role
The researchers believe exposure to colibactin often occurs in early childhood, likely within the first decade of life. Alexandrov explained, “If you acquire these mutations at age 5, that puts you 20 to 30 years ahead of schedule for developing colorectal cancer.” Importantly, the data suggest that the damage happens long before the cancer is diagnosed.
Environmental and Lifestyle Triggers
Experts emphasize that colibactin alone cannot explain the surge in colorectal cancer. Christian Jobin, a microbiome researcher at the University of Florida, noted that it is likely one factor among many—including diet, sedentary lifestyles, inflammation, and medication use—that collectively speed up cancer development.
Indeed, colibactin-producing E. coli strains are present in 20–30% of people, but not everyone carrying them develops cancer. Jobin pointed out that diet, antibiotic use, and early-life exposures may determine when these bacteria activate their “toxin weaponry.”
Global Patterns and Suspected Risk Factors
As reported by npr.org, the study found colibactin-related mutations to be rare in rural, non-industrialized regions of Africa and Asia but more common in Western nations. This pattern suggests environmental factors—such as mode of birth, breastfeeding practices, antibiotics, and ultra-processed food consumption—may shape the microbiome in ways that encourage harmful bacterial activity.
Future Directions
Researchers caution that more work is needed to prove causation. Still, they hope to identify microbes that can act as biomarkers for cancer risk and eventually design drugs to neutralize toxins like colibactin. Gastroenterologist Dr. Neelendu Dey stressed the need for caution, noting that altering the microbiome can have unpredictable consequences.
A Complex Puzzle
While colibactin may not be the single “skeleton key” to rising colorectal cancer rates, this research offers a crucial clue. By uncovering how bacterial toxins interact with human health, scientists are opening new pathways to prevention, early detection, and safer interventions for one of the fastest-growing cancers in young adults.